Rank #1: Emotional processing in functional neurological disorder (FND)
Dr. Susannah Pick (King’s College London, UK) discusses emotional processing in functional neurological disorder, and how further understand of emotional processing deficits may help contribute to a unified explanatory model for FND.
Jun 12 2019
12mins
Rank #2: BNPA 2013: The neural correlates of Freudian “repression” in conversion disorder
Selma Aybek, clinician researcher, Service of Neurology, University of Lausanne, has been examining the process which allows psychological stressors to become physical symptoms in conversion disorder. Chris Butler, academic clinical lecturer in neurology, University of Oxford, asks her what she’s found.
This podcast was recorded at the British NeuroPsychiatry Association’s 2013 AGM. For more information on the association and next year’s meeting, see bnpa.org.uk.
Feb 18 2013
7mins
Rank #3: Evolution or revolution? Should we re-think clinical practice?
In the second half of this podcast, Professor Ryuji Kaji (Tokushima University, Japan) discusses the pathogenesis of dystonia (uncontrolled movements). Is it a basal ganglia or cerebellar disorder? Or both? Read the full paper here: http://jnnp.bmj.com/content/89/5/488.
Apr 30 2018
18mins
Rank #4: Frontotemporal dementia reviewed; temporal orientation and dementia
Recent clinical, neuropsychological, imaging, genetic and pathological developments have changed our understanding of frontotemporal dementia, its classification and criteria. Dr Jonathan Rohrer, Dementia Research Centre, UCL Institute of Neurology, London, talks about these advances and future research directions.
Also in this edition, Dr Shaun O’Keeffe, Merlin Park University Hospital, Dublin, explains how simple questions about time are, and should be, used to assess dementia and delirium.
See also:
Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review http://tinyurl.com/barrt7s
Orientation to time as a guide to the presence and severity of cognitive impairment in older hospital patients http://tinyurl.com/ajaqsa4
Jan 29 2013
18mins
Rank #5: Diagnosing conversion disorder; exercise to prevent falls in Parkinson’s patients
In this edition Richard Kanaan (Institute of Psychiatry, King’s College London) talks about his work on conversion disorder, and gives his advice for neurologists and psychiatrists on making this tricky diagnosis.
And Vicki Goodwin (Peninsula College of Medicine and Dentistry, University of Exeter) discusses her trial on whether an exercise intervention could prevent falls in those with Parkinson’s disease.
See also:
Conversion disorder: a problematic diagnosis http://tinyurl.com/agrtdxs
An exercise intervention to prevent falls in people with Parkinson’s disease: a pragmatic randomised controlled trial http://tinyurl.com/b2d697b
Feb 15 2013
21mins
Rank #6: Neurological symptoms from autoimmune syndromes; movement disorders and OCD; counting strokes
This month, editor Matthew Kiernan discusses new guidelines for recognising central nervous system neuronal surface antibody associated symptoms with Angela Vincent (emeritus professor of neuroimmunology at Oxford University).
Danielle Cath (psychiatrist at Altrecht Academic Anxiety Outpatients Clinics, Utrecht University) explains what her review of the relationship between obsessive compulsive disorder and movement disorders reveals.
And Charles Warlow (emeritus professor of medical neurology at the University of Edinburgh) looks back on his highly cited 1988 paper on incidence, outcome and type of stroke in Oxfordshire.
See also:
Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition http://tinyurl.com/avn64sl
Relationship between movement disorders and obsessive–compulsive disorder: beyond the obsessive–compulsive–tic phenotype. A systematic review http://tinyurl.com/b8vk32g
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project, 1981–86 http://tinyurl.com/ax26xlk
Feb 15 2013
34mins
Rank #7: The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies
Read the review published by JNNP here: http://jnnp.bmj.com/content/early/2016/09/09/jnnp-2016-314123.abstract.
Nov 30 2016
11mins
Rank #8: Re-evaluating the treatment of acute optic neuritis
Elliot Frohman is Professor of Neurology and Neurotherapeutics and Ophthalmology and Director of the Multiple Sclerosis and Neuroimmunology Program, at the University of Texas.
Read the full paper here:
http://jnnp.bmj.com/content/early/2014/10/29/jnnp-2014-308185.full
Feb 10 2016
19mins
Rank #9: Is it time to focus on the common pathways linking neurodegenerative diseases?
Dr. Ahmed and colleagues critically evaluate a new approach to neurodegenerative disease, a focus on phenotypic presentation opposed to syndromic diagnosis. Via collaborative efforts, should we be looking at the commonalities between the neurodegenerative diseases?
Read the full article here: http://jnnp.bmj.com/content/early/2016/05/12/jnnp-2014-308350.full.
Oct 13 2016
13mins
Rank #10: BNPA special: Autoimmune encephalitis
Angela Vincent, emeritus professor of neuroimmunology at the University of Oxford, gives Adam Zeman, professor of cognitive and behavioural neurology, University of Exeter, an overview of autoimmune disorders of the central nervous system.
This podcast is one of several recorded with the British Neuropsychiatry Association, more of which will be published over the next few months. For all the podcasts in this series, see: soundcloud.com/tags/bnpa%202014
Mar 14 2014
10mins
Rank #11: Pathophysiology of functional neurological disorder
Despite the prevalence of the disease, neurologists and psychiatrists can be wary of treating patients with functional neurological disorder (FND). Assistant Professor David Perez (Massachusetts General Hospital, USA) discusses how FND sits between neurological and psychiatric disciplines, the relationship between poor health status and affective symptoms, and associations with grey matter volumetric profiles. Read more here: http://jnnp.bmj.com/content/88/12/1052.
Dec 13 2017
11mins
Rank #12: Diagnosing and treating neuromyelitis optica
Neuromyelitis optica (NMO) is an autoimmune inflammatory disorder with predilection for the optic nerves and spinal cord. Many recent advances, in particular, the discovery of NMO-IgG, an NMO-specific autoantibody, have furthered our understanding of the condition.
Anu Jacob, consultant neurologist, The Walton Centre for Neurology and Neurosurgery, Liverpool, summarises what clinicians need to know in terms of diagnosing and treating NMO and its spectrum disorders.
Read the full review, for free, here: http://goo.gl/fidlGL
Aug 19 2013
21mins
Rank #13: Diagnosing and treating functional symptoms
February's JNNP is a neuropsychiatry special issue, with papers on a broad range of disorders which lie between neurology and psychiatry. Associate editor Alan Carson discusses the contents, and the thinking behind the edition.
To accompany the issue, JNNP and the Association of British Neurologists convened a roundtable of experts to discuss, and advise on, diagnosing and treating functional symptoms. Dr Carson takes part in this, along with:
Kailash Bhatia, professor of neurology, Institute of Neurology
Mark Edwards, neurologist at the National Hospital for Neurology and Neurosurgery
Jon Stone, neurologist, University of Edinburgh, Western General Hospital
This podcast is one of a series produced in collaboration with the Association of British Neurologists. You can find all the podcasts in the series here: soundcloud.com/tags/abn%202013
Jan 10 2014
27mins
Rank #14: BNPA 2013: Psychedelic drugs, magical thinking and psychosis
Robin Carhart-Harris, post-doctoral researcher, Division of Brain Sciences, Imperial College London, explains his hypothesis on the shared neurobiology of psychosis, psychedelic states and spontaneous spiritual experiences to Peter Halligan, professor in the School of Psychology, Cardiff University.
This podcast was recorded at the British NeuroPsychiatry Association’s 2013 AGM. For more information on the association and next year’s meeting, see bnpa.org.uk.
Feb 18 2013
6mins
Rank #15: Can cocoa help with fatigue in MS
Dr Shelly Coe (Oxford Brookes University, Oxford) discusses a new randomized control trial looking at the use of cocoa for management of fatigue in multiple sclerosis. Read the full paper here: https://jnnp.bmj.com/content/90/5/507
May 28 2019
7mins
Rank #16: Idiopathic intracranial hypertension; discovering the neurological effects of critical illness
This month Beau Bruce (assistant professor of ophthalmology and neurology, Emory University School of Medicine, Atlanta) discusses what we do and don’t know about idiopathic intracranial hypertension, and offers some clinical advice on the syndrome for neurologists.
And Charles Bolton (professor in the Department of Medicine, Queen’s University, Ontario, Canada) talks us through his investigations in the 1980s which discovered critical illness could cause neurological problems.
See also:
Update on the pathophysiology and management of idiopathic intracranial hypertension http://tinyurl.com/bhjc9h6
Polyneuropathy in critically ill patients http://tinyurl.com/bbze6jc
Feb 15 2013
23mins
Rank #17: Discovering Emery-Dreifuss muscular dystrophy, and flavour identification in FTLD
In the last JNNP podcast of 2012, we look at what jelly beans and the Andalucian mountains have done for neurology and psychiatry.
Alan Emery, emeritus professor, Green Temple College, University of Oxford, describes studying the family that led him to delineate Emery-Dreifuss muscular dystrophy.
And Jason Warren and Rohani Omar, UCL Institute of Neurology, talk about what their study into flavour identification in frontotemporal lobar degeneration reveals.
See also:
Impact commentary: Unusual type of benign X linked muscular dystrophy http://tinyurl.com/aszzjty
Original paper: Unusual type of benign X linked muscular dystrophy http://tinyurl.com/bjadyod
Flavour identification in frontotemporal lobar degeneration http://tinyurl.com/a8zh35u
Feb 15 2013
22mins
Rank #18: Intravenous immunoglobulin in CIDP
Can IViG be used as a longer term maintenance therapy for CIDP patients? JNNP Associate Editor, Professor Satoshi Kuwabara (Chiba University Hospital, Japan) joins us for this podcast, discussing recent trial results and their implications for patient care. Read the full paper here: http://jnnp.bmj.com/content/88/10/832
Oct 23 2017
11mins
Rank #19: BNPA 2014: Schizophrenia and cognition
In this podcast Alan Carson discusses the question with Eileen Joyce, Consultant Neuropsychiatrist at the National Hospital for Neurology and Neurosurgery. She argues that there is a limited general resource in schizophrenia that constrains the performance of a wide range of specific cognitive functions and underlies the development of psychotic symptoms as well as determining functional outcome. She also outlines the possible neurobiological underpinnings.
This podcast was recorded at the 2014 British NeuroPsychiatry Association AGM.
Dec 02 2014
8mins
Rank #20: BNPA 2014: Joint hypermobilty and autonomic hyperactivity
Read the abstract: http://jnnp.bmj.com/content/85/8/e3.40.abstract
This podcast was recorded at the 2014 British NeuroPsychiatry Association AGM.
Sep 17 2014
5mins
